Test Termination: Relative & Absolute Indications

ACSM Certified Clinical Exercise Physiologist ACSM-CEP

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 The ACSM-CEP Role, Job Definition & Scope of Practice 1.2 Exam Format, Domain Weights & Scoring 1.3 Eligibility, Study Planning & Test-Day Strategy

2 Applied Exercise Physiology & Metabolic Calculations

Bioenergetics & Energy Systems (ATP-PC, glycolytic, oxidative) Acute Cardiorespiratory & Metabolic Responses to Aerobic Exercise Responses to Resistance Exercise & Chronic Training Adaptations ACSM Metabolic Equations, METs & Interpreting VO₂ / RER / Ventilatory Threshold

3 Pathophysiology of Clinical Populations

3.1 Coronary Artery Disease, Myocardial Infarction & Revascularization (PCI/CABG) 3.2 Heart Failure, Valvular Disease & Cardiac Rhythm Disorders 3.3 Hypertension, Dyslipidemia & Peripheral Artery Disease 3.4 Pulmonary Disease: COPD, Asthma & Restrictive/Interstitial Disorders 3.5 Diabetes, Metabolic Syndrome & Obesity 3.6 Renal Disease & Musculoskeletal/Orthopedic Conditions 3.7 Neuromuscular, Neurological & Cognitive Conditions (stroke, MS, Parkinson's, SCI) 3.8 Neoplastic, Immunologic & Hematologic Disorders (cancer, HIV/AIDS, anemia)

4 Clinical ECG Interpretation

4.1 ECG Leads, Waveforms, Rate & Rhythm Determination 4.2 Arrhythmias & Conduction Blocks 4.3 Ischemia, Injury & Infarction (ST changes, exercise-induced) 4.4 Drug & Electrolyte ECG Effects; Resting/Exercise Monitoring Setup & Lead Placement

5 Pharmacology for the Clinical Exercise Physiologist

5.1 Beta-Blockers, Calcium-Channel Blockers & Nitrates 5.2 RAAS Agents, Diuretics, Antiarrhythmics, Lipid-Lowering & Antithrombotic Drugs 5.3 Bronchodilators, Corticosteroids, Insulin & Oral Antidiabetic Agents 5.4 Medication Effects on HR/BP & Exercise Response; Dose/Meal/Dialysis Timing

6 Patient Assessment (Domain I, 18%)

6.1 Medical Records, HIPAA/HITRUST, Charting & Physician Referral 6.2 Patient Interview, Medical History & Medication Reconciliation 6.3 Resting Vital Signs, Body Composition & Resting ECG 6.4 Preparticipation Health Screening & Level of Monitoring (PAR-Q+, ACSM algorithm, ACC/AHA · GOLD · ADA · AACVPR) 6.5 Assessing Patient Goals, Readiness & Psychosocial Status

7 Clinical Exercise Testing (Domain II, 18%)

Submaximal Aerobic Tests (treadmill, cycle, step, 6-minute walk) Musculoskeletal Fitness, Mobility & Balance Testing Maximal Symptom-Limited GXT: Protocols, Contraindications & ECG Prep Test Termination: Relative & Absolute Indications Interpreting & Reporting Results (ECG response, RPP, claudication, Duke Treadmill Score, VO₂/RER/AT)

8 Exercise Prescription for Clinical Populations (Domain III, 22%)

FITT-VP Principles, Progression & Prescription Foundations Ex Rx for Cardiovascular Disease (CAD, HF, HTN, PAD, post-revascularization) Ex Rx for Pulmonary Disease (COPD, asthma; breathing techniques, supplemental O2) Ex Rx for Diabetes, Metabolic Syndrome & Obesity Ex Rx for Musculoskeletal, Neuromuscular, Neoplastic & Other Conditions Communicating Intensity (THR, RPE, talk test), Monitoring & Modifying the Prescription

9 Exercise Training & Leadership (Domain IV, 24%)

9.1 Discussing the Training Plan, Clinician & Patient Expectations/Goals 9.2 Instructing & Modifying Exercise Modes (cardiorespiratory, strength/endurance, flexibility, coordination, agility) 9.3 Patient Monitoring & Supervision During Exercise (telemetry, oximetry, glucometry, ECG) 9.4 Contraindications to Training & Modifying Recommendations 9.5 Documenting Clinical Status, Reporting Adverse Events & Interdisciplinary Coordination

10 Education & Behavior Change (Domain V, 13%)

10.1 Behavioral-Health Screening & Recognizing Distress (PHQ-9, Beck, SF-36; referral) 10.2 Patient Education, Health Literacy & Disease Self-Management 10.3 Motivational Interviewing & Behavior-Change Theories (Transtheoretical, HBM, Social Cognitive, Five-A's) 10.4 Promoting Adherence, Self-Efficacy, Relapse Prevention & Social Support

11 Legal, Professional & Emergency Management (Domain VI, 5%)

11.1 Emergency Equipment, Crash Cart Inspection & Emergency Procedures 11.2 CPR/AED/BLS/ACLS, Universal Precautions & EMS Activation 11.3 Scope of Practice, Legal/Ethical Standards, Liability/Negligence, Informed Consent & Professional Organizations (ACSM/AACVPR/AHA)

Test Termination: Relative & Absolute Indications

Key Takeaways Explain This Topic AI

Absolute indications for terminating a test — including sustained ventricular tachycardia, moderate-to-severe angina, and the patient's request to stop — require immediate termination with no exceptions.

Relative indications — such as marked ST displacement, increasing chest pain, or arrhythmias other than sustained VT — call for clinical judgment; the test usually stops but may continue only with close monitoring.

A patient's own request to stop is, by itself, an absolute indication for termination.

Termination should use a gradual workload reduction rather than an abrupt stop, with ECG, blood pressure, and symptom monitoring continuing uninterrupted.

Post-test monitoring should continue for at least 6-8 minutes into recovery, since roughly 85% of abnormal responses appear during exercise or within the first 5-6 minutes of recovery.

Last updated: July 2026

Test Termination: Relative & Absolute Indications

Continuous monitoring during a maximal GXT — ECG rhythm assessed throughout, blood pressure measured each stage, RPE recorded on the Borg 6-20 scale each stage, and constant observation for signs and symptoms such as chest discomfort, dyspnea, dizziness, pallor, or gait unsteadiness — exists for one reason: to catch the point at which continuing the test becomes riskier than stopping it. ACSM organizes that decision into two tiers, absolute and relative, and every CEP must recognize both without hesitation, since a symptom-limited GXT deliberately pushes a patient toward their physiologic limit.

Absolute Indications — Stop the Test Immediately

When any of the following appear, the test is stopped immediately regardless of workload, elapsed time, or how close the patient is to a target endpoint:

Drop in systolic blood pressure of more than 10 mmHg from baseline (despite an increase in workload) when accompanied by other evidence of ischemia

Moderate-to-severe angina
Increasing nervous-system symptoms (e.g., ataxia, dizziness, near-syncope)
Signs of poor perfusion (cyanosis or pallor)
Technical difficulty monitoring the ECG or systolic blood pressure
The patient's request to stop
Sustained ventricular tachycardia
ST-segment elevation of more than 1 mm in leads without diagnostic Q waves (excluding aVR, aVL, and V1)
Relative Indications — Stop Unless Continuing Is Clearly Justified

Relative indications call for clinical judgment: the test is usually stopped, but the supervising clinician may continue with close monitoring if there is a compelling reason and no absolute finding is present.

Drop in systolic blood pressure of 10 mmHg or more from baseline, persisting below baseline, without other evidence of ischemia

Marked ST-segment displacement (horizontal or downsloping depression greater than 2 mm)

Arrhythmias other than sustained ventricular tachycardia — including multifocal PVCs, ventricular triplets, supraventricular tachycardia, bradyarrhythmias, or heart block — with the potential to become more complex or hemodynamically destabilizing

Fatigue, shortness of breath, wheezing, leg cramps, or claudication

Development of bundle-branch block or an intraventricular conduction delay that cannot be distinguished from ventricular tachycardia

Increasing chest pain
Hypertensive response (systolic blood pressure above 250 mmHg and/or diastolic blood pressure above 115 mmHg)
Absolute vs. Relative: The Core Distinction

Absolute Relative

Action Stop immediately, no exceptions Usually stop; may continue only with clinical judgment and close monitoring

Basis Finding itself signals immediate danger Finding raises risk but benefit of continuing may outweigh it in context

Example Sustained VT, patient request to stop Multifocal PVCs, increasing chest pain
How to Stop the Test Safely

Termination should not mean an instantaneous, jarring halt. On a treadmill, reduce speed and grade gradually or transition to a brief low-level cool-down stage rather than an abrupt stop, which can itself trigger hypotension or a vasovagal response. On a cycle ergometer, reduce resistance toward zero while the patient continues slow pedaling. In either case, ECG, blood pressure, and symptom monitoring continue uninterrupted through the transition — termination is a change in workload, not a pause in surveillance. Note that for tests where diagnostic ECG accuracy is the priority, a continued walking cool-down can delay or mask the appearance of exercise-induced ST depression, so some diagnostic protocols favor an immediate seated recovery position instead.

Post-Test Recovery Monitoring

The test is not over when the treadmill stops. Continue ECG, blood pressure, and symptom monitoring for at least 6-8 minutes into recovery , or until heart rate, blood pressure, and ST segments return toward baseline — approximately 85% of abnormal responses appear either during exercise or within the first 5-6 minutes of recovery. Blood pressure surveillance is especially important because post-exercise hypotension is common as venous return drops with the sudden decrease in muscle pump activity.

Documentation

Whatever the reason for termination, document the time and stage/workload at termination, peak heart rate and blood pressure, peak RPE, relevant ECG findings, and the specific sign, symptom, or patient report that triggered stopping. This record directly informs the interpretation and reporting covered next, and shapes the referring physician's follow-up plan.

When Termination Signals an Emergency

Most terminations end in an uneventful recovery, but the CEP must be ready to escalate immediately when an absolute indication reflects a true emergency — sustained ventricular tachycardia, signs of poor perfusion, or a patient who becomes hemodynamically unstable. Emergency equipment (crash cart, AED, supplemental oxygen) should be checked and accessible before every test session begins, and the facility's emergency action plan — including who activates EMS and who continues monitoring and treatment until help arrives — should already be rehearsed rather than improvised in the moment. Chapter 11 covers emergency equipment readiness and BLS/ACLS response in full; the point to internalize here is that termination criteria and emergency response are two links in the same safety chain, and hesitating to apply an absolute indication because a patient is "so close" to finishing a stage is a preventable error.